Search results for “Hereditary angioedema” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 458 patents, we discovered top 35 key players by total patent application. Takeda Pharmaceutical Co., Ltd., Bayer Pharma AG, Dyax Corp. are dominant in this area. They take 42.36% of the total patent filing.
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 115
Bayer Pharma AG
Berlin, Germany
Patent: 42
Dyax Corp.
Massachusetts, United States
Patent: 37
KalVista Pharmaceuticals Ltd.
United Kingdom
Patent: 28
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 24
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 22
CSL Behring GmbH
Hessen, Germany
Patent: 19
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 15
BioMarin Pharmaceutical, Inc.
California, United States
Patent: 15
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 12
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 11 patents, we discovered top 3 start-ups by total patent application.
STARTUP
Orchard Therapeutics (Europe) Ltd.
United Kingdom
Patent: 5
STARTUP
Attune Pharmaceuticals, Inc.
New York, United States
Patent: 4
STARTUP
HVH Precision Analytics LLC
Pennsylvania, United States
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 232 patents applied in the last 5 years. We discover 31 most active companies in this area. The fast-growing Takeda Pharmaceutical Co., Ltd., KalVista Pharmaceuticals Ltd., Ionis Pharmaceuticals, Inc. take 38.36% of patent filing during this period.
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 54
KalVista Pharmaceuticals Ltd.
United Kingdom
Patent: 19
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 16
BioMarin Pharmaceutical, Inc.
California, United States
Patent: 15
Dyax Corp.
Massachusetts, United States
Patent: 14
Merck Sharp & Dohme LLC
New Jersey, United States
Patent: 12
Intellia Therapeutics, Inc.
Massachusetts, United States
Patent: 11
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 10
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 8
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 7
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 232 patents in last 5 years, we discover 19 new entrants. BioMarin Pharmaceutical, Inc., Merck Sharp & Dohme LLC, Intellia Therapeutics, Inc. are the most active new entrants in this area.
BioMarin Pharmaceutical, Inc.
California, United States
Patent: 15
Merck Sharp & Dohme LLC
New Jersey, United States
Patent: 12
Intellia Therapeutics, Inc.
Massachusetts, United States
Patent: 11
CSL Innovation Pty Ltd.
Australia
Patent: 7
Peking Union Medical College Hospital
Beijing Shi, China
Patent: 5
STARTUP
Orchard Therapeutics (Europe) Ltd.
United Kingdom
Patent: 5
Centogene AG
Mecklenburg-Vorpommern, Germany
Patent: 4
STARTUP
Attune Pharmaceuticals, Inc.
New York, United States
Patent: 4
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 4
Suzhou Ruibo Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 15 patents, we discovered top 4 universities and scientific research institutions by total patent application. Cornell University, The University of Queensland, University of Tokyo are dominant in this area. They take 100.00% of the total patent filing.
Cornell University
New York, United States
Patent: 13
The University of Queensland
Queensland, Australia
Patent: 1
University of Tokyo
Tokyo-to, Japan
Patent: 1
Shanghai Institute of Pharmaceutical Industry
Shanghai Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: